| Authors: |
López Rivera M; Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Chang RB; Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Lewis CM; Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA., Hadary R; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, 7610001, Israel., Kovalski JM; Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA., Freeman KG; Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA., Sun ZJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Sorek R; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, 7610001, Israel., Hatfull GF; Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA., Kranzusch PJ; Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute, Boston, MA 02115, USA. |
